• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定天然抗病毒化合物作为基孔肯雅病毒非结构蛋白3大结构域的潜在抑制剂。

identification of natural antiviral compounds as a potential inhibitor of chikungunya virus non-structural protein 3 macrodomain.

作者信息

Chaudhary Meenakshi, Sehgal Deepak

机构信息

Department of Life Sciences, School of Natural Sciences, Shiv Nadar University, Greater Noida, Uttar Pradesh, India.

出版信息

J Biomol Struct Dyn. 2022;40(22):11560-11570. doi: 10.1080/07391102.2021.1960195. Epub 2021 Aug 6.

DOI:10.1080/07391102.2021.1960195
PMID:34355667
Abstract

Chikungunya Virus (CHIKV) is having a major impact on humans with potentially life-threatening and debilitating arthritis. The lack of a specific antiviral drug against the CHIKV disease has created an alarming situation to identify or develop potent chemical molecules for its remedial measures. Antiviral therapies for viral diseases are generally expensive and have adverse side effects. Plant-based antiviral natural compounds are the most suitable and best alternative of current antiviral drugs because of less toxicity. In the present study, non-structural protein 3 macrodomain (nsP3) of the CHIKV that is essential for virus replication has been selected for anti CHIKV drug target. The compounds were identified using molecular docking, virtual screening and further evaluated by molecular dynamics (MD) simulation studies. The binding mechanism of each compound was analyzed considering the stability and energetic parameter. We have found six plant-based natural antiviral compounds Baicalin, Rutaecarpine, Amentoflavone, Apigetrin, Luteoloside, and Baloxavir as strong inhibitors of nsP3 of CHIKV. ADMET prediction and target analysis of the selected compounds showed drug likeliness of these compounds. MD simulation studies indicated energetically favorable complex formation between nsP3 and the selected antiviral compounds. Furthermore, the structural effects on these substitutions were analyzed using the principles of each trajectory, which validated the interaction studies. Our analysis suggests a very high probability of these compounds to inhibit nsP3 of CHIKV and could be evaluated for Chikungunya fever drug development. Communicated by Ramaswamy H. Sarma.

摘要

基孔肯雅病毒(CHIKV)正在对人类产生重大影响,可引发可能危及生命且使人衰弱的关节炎。缺乏针对基孔肯雅病毒病的特效抗病毒药物,这促使人们迫切需要识别或开发有效的化学分子用于补救措施。针对病毒性疾病的抗病毒疗法通常价格昂贵且有不良副作用。基于植物的抗病毒天然化合物因其低毒性,是当前抗病毒药物最合适且最佳的替代品。在本研究中,已选择对病毒复制至关重要的基孔肯雅病毒非结构蛋白3宏结构域(nsP3)作为抗基孔肯雅病毒药物靶点。通过分子对接、虚拟筛选鉴定化合物,并通过分子动力学(MD)模拟研究进一步评估。考虑稳定性和能量参数分析了每种化合物的结合机制。我们发现六种基于植物的天然抗病毒化合物黄芩苷、吴茱萸次碱、穗花杉双黄酮、芹菜素、木犀草苷和巴洛沙韦是基孔肯雅病毒nsP3的强抑制剂。对所选化合物的ADMET预测和靶点分析表明这些化合物具有成药可能性。MD模拟研究表明nsP3与所选抗病毒化合物之间能形成能量有利的复合物。此外,利用每条轨迹的原理分析了这些取代对结构的影响,验证了相互作用研究。我们的分析表明这些化合物极有可能抑制基孔肯雅病毒的nsP3,可用于评估开发治疗基孔肯雅热的药物。由拉马斯瓦米·H·萨尔马传达。

相似文献

1
identification of natural antiviral compounds as a potential inhibitor of chikungunya virus non-structural protein 3 macrodomain.鉴定天然抗病毒化合物作为基孔肯雅病毒非结构蛋白3大结构域的潜在抑制剂。
J Biomol Struct Dyn. 2022;40(22):11560-11570. doi: 10.1080/07391102.2021.1960195. Epub 2021 Aug 6.
2
In silico identification of chikungunya virus replication inhibitor validated using biochemical and cell-based approaches.通过生化和基于细胞的方法验证了基孔肯雅病毒复制抑制剂的计算机鉴定。
FEBS J. 2024 Jun;291(12):2656-2673. doi: 10.1111/febs.17066. Epub 2024 Feb 1.
3
Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.基于结构的虚拟筛选、3D-QSAR、分子动力学和 ADMET 研究,以选择针对基孔肯雅热结构和非结构靶标的天然抑制剂。
J Biomol Struct Dyn. 2019 Aug;37(12):3150-3161. doi: 10.1080/07391102.2018.1509732. Epub 2018 Dec 28.
4
In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus.体外和体内研究表明,来自藤黄科藤黄属植物的一种紫檀芪,α-倒捻子素,是一种有前途的抗基孔肯雅病毒的天然抗病毒化合物。
Virol J. 2021 Feb 28;18(1):47. doi: 10.1186/s12985-021-01517-z.
5
Development of a theoretical model for the inhibition of nsP3 protease of Chikungunya virus using pyranooxazoles.使用吡喃并恶唑抑制基孔肯雅病毒nsP3蛋白酶的理论模型的建立
J Biomol Struct Dyn. 2020 Jul;38(10):3018-3034. doi: 10.1080/07391102.2019.1650830. Epub 2019 Aug 13.
6
Is the ADP ribose site of the Chikungunya virus NSP3 Macro domain a target for antiviral approaches?基孔肯雅病毒 NSP3 巨结构域的 ADP-核糖基位点是否是抗病毒方法的靶点?
Acta Trop. 2020 Jul;207:105490. doi: 10.1016/j.actatropica.2020.105490. Epub 2020 Apr 23.
7
identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase.鉴定和验证天然抗病毒化合物作为 SARS-CoV-2 甲基转移酶潜在抑制剂的研究
J Biomol Struct Dyn. 2022 Sep;40(14):6534-6544. doi: 10.1080/07391102.2021.1886174. Epub 2021 Feb 15.
8
Host Factor Nucleophosmin 1 (NPM1/B23) Exerts Antiviral Effects against Chikungunya Virus by Its Interaction with Viral Nonstructural Protein 3.宿主因子核仁磷酸蛋白 1(NPM1/B23)通过与病毒非结构蛋白 3 的相互作用发挥抗病毒作用对抗基孔肯雅病毒。
Microbiol Spectr. 2023 Aug 17;11(4):e0537122. doi: 10.1128/spectrum.05371-22. Epub 2023 Jul 6.
9
Design, synthesis and anti-Chikungunya virus activity of lomerizine derivatives.洛美利嗪衍生物的设计、合成及抗基孔肯雅病毒活性
Bioorg Med Chem Lett. 2023 Mar 1;83:129188. doi: 10.1016/j.bmcl.2023.129188. Epub 2023 Feb 15.
10
Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.设计、合成、抗病毒评估及针对基孔肯雅病毒 nsP2 的丙烯酰胺类化合物的计算机研究。
Eur J Med Chem. 2023 Oct 5;258:115572. doi: 10.1016/j.ejmech.2023.115572. Epub 2023 Jun 19.

引用本文的文献

1
Methotrexate, an anti-inflammatory drug, inhibits Hepatitis E viral replication.甲氨蝶呤,一种抗炎药物,可抑制戊型肝炎病毒复制。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2280500. doi: 10.1080/14756366.2023.2280500. Epub 2023 Nov 17.
2
Growth in chikungunya virus-related research in ASEAN and South Asian countries from 1967 to 2022 following disease emergence: a bibliometric and graphical analysis.1967 年至 2022 年虫媒病毒相关研究在东盟和南亚国家的增长:文献计量和图形分析。
Global Health. 2023 Feb 6;19(1):9. doi: 10.1186/s12992-023-00906-z.
3
Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways.
咪唑并[1,2-a]吡啶并[2,3-d]嘧啶对基孔肯雅病毒复制的影响:干扰素 1 型途径依赖性和非依赖性的抗病毒活性。
Virus Res. 2023 Jan 15;324:199029. doi: 10.1016/j.virusres.2022.199029. Epub 2022 Dec 22.